Issue 53 • August 2022

The future of ALS devices

Reproductive tech: a fertile area for investment

Trends in medical nanotechnology

Beyond biopsy: how noninvasive NASH tests can move the needle

There are a variety of noninvasive NASH tests currently available and under investigation—but how can they be optimised?

In association with

07/29/2022 09:04:43
  • Home | Beyond biopsy: how noninvasive NASH tests can move the needle
  • In this issue
  • Contents
  • Briefing
  • Industry news
  • The medical industry briefing
  • Sartorius
  • Comment
  • Securing the future foundation for a digital NHS
  • Increased surveillance drives monkeypox virus in-vitro diagnostic test market
  • New monkeypox testing kits in development
  • In Depth
  • Beyond biopsy: how noninvasive NASH tests can move the needle
  • The future of ALS devices: next gen assistive technology aims to give patients a
  • Reproductive tech: a fertile area for investment
  • Nanotechnology Trends in Medicine
  • Sandvik Company Insight
  • Sandvik
  • In Data
  • J&J is top medical industry cloud innovator in latest quarter ending May
  • AI deals in medical industry dropped in H1 2022
  • Data analytics hiring in medical industry rose in June 2022
  • Events
  • Next Issue